Linical Americas   Report issue

For profit Phase 1 Phase 2
Founded: Stuart FL United States (2005)

Organization Overview

First Clinical Trial
2020
NCT04601428
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Linical Americas | Linical Korea Co., Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

hzvsf-v13 (1 trial)

Drugs in Phase 1 Trials (1)

csr02-fab-tf (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2